Banfi Wines Combines Innovation and Legacy to Lead a Surging Wine Industry
Innovative Industrial Properties Helps the NYSE Make History
Charles & Colvard (CTHR): a Moissanite in the Rough
This Week in Emerging Growth: And Lo, the Road to Paradise Was Paved With Gas Furnace Factories in Indiana
Election Rally Fading? The Nasdaq Erased All Its Post Election Gains
Roelof Rongen of Matinas BioPharma joins Equities.com to discuss his company's focus on omega-3-based prescription therapeutics and why most people underestimate the fatty acid group.
You have to be logged in to leave a comment.
I'm sorry, but in order to complete what you're trying to do, you must be logged in.
© 2016 Equities
* All dates and time are being displayed in Eastern Standard Time (EST).